 | Vivos Therapeutics, Inc. | |||
| NCM : VVOS || Location: United States | ||||
$2.57-0.08 (-3.02%) |
0.07 M | 2.55 - 2.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.019 M |
| March 15, 2024 | 0.026 M |
| Feb. 29, 2024 | 0.024 M |
| Feb. 15, 2024 | 0.029 M |
| Jan. 31, 2024 | 0.047 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.94 | -3.05 | -56.97% |
| 09/30/2023 | -3.19 | -1.62 | 49.18% |
| 06/30/2023 | -3.70 | -4.50 | -21.70% |
| 03/31/2023 | -4.59 | -1.75 | 61.87% |
| 12/31/2022 | -0.22 | -0.20 | 9.10% |
VVOS Basic Data
| Sector | Healthcare | Industry | Medical Devices |
| Shares Outstanding | 2.982M | Shares Float | 1.932M |
| Short Float | 0.019M | Market Cap | 7.90M |
| Institution ownership | 13.73% | Insider ownership | 7.390% |
| Earnings Date | 06/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -11.14 | Forward EPS | -2.28 |